Managing Benzodiazepine Withdrawal-The Emperor's New Clothes

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Lewis Katz School of Medicine, Tuttleman Counseling Services, Temple University, Philadelphia, PA pdemaria@temple.edu.

Peter A DeMaria Jr. J Addict Med. 2023 Sep-Oct.

. 2023 Sep-Oct;17(5):626-627.

doi: 10.1097/ADM.0000000000001181. Epub 2023 May 17.

¹ Department of Psychiatry and Behavioral Sciences, Lewis Katz School of Medicine, Tuttleman Counseling Services, Temple University, Philadelphia, PA pdemaria@temple.edu.

No abstract available

Conflict of interest statement

The authors report no conflict of interest.

1. Lader M, Kyriacou A. Withdrawing benzodiazepines in patients with anxiety disorders. Curr Psychiatry Rep . 2016;18(1):8.
1. Messinger JC, Hakimi E, Vercollone L. The use of a single dose of phenobarbital for inpatient management of benzodiazepine withdrawal: A case report. J Addict Med . 2023;17(2):230–232.
1. The ASAM National Practice Guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med . 2020;14(2S):1–91.
1. Couvée JE, Timmermans MAY, Zitman FG. Dutch chronic benzodiazepine working group. The long-term outcome of a benzodiazepine discontinuation programme in depressed outpatients. J Affect Disord . 2002;70(2):133–141.
1. Voshaar RCO, Gorgels WJ, Mol AJ, et al. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program. Can J Psychiatry . 2006;51(7):445–452.